The world’s largest collection of jobs backed by Venture Capital & Private Equity firms

LEXEO Therapeutics
LEXEO Therapeutics
alexandria venture investments
alzheimer's drug discovery foundation
cam capital
d1 capital partners
eventide asset management
gray's creek capital partners
intus capital
janus henderson investors
laurion capital management
longitude capital
lundbeckfonden ventures
omega funds
pbm capital group
verition fund management
woodline partners
2. 11-50

LEXEO Therapeutics is a fully integrated clinical-stage gene therapy company advancing disease-modifying treatments for genetic cardiovascular conditions and genetic conditions of the central nervous system (CNS). The company aims to apply cutting-edge science to target the underlying causes of both rare monogenic diseases and diseases affecting large patient populations. LEXEO’s current pipeline consists of adeno-associated virus (AAV)-mediated gene therapies in rare cardiac diseases, CLN2 Batten disease, and APOE4-associated Alzheimer’s disease. In addition, the company has more than 15 AAV-mediated gene therapy programs in research and development. LEXEO was founded based on well-established gene therapy research legacy at Weill Cornell Medicine’s Department of Genetic Medicine by a team of pioneering scientists, clinicians, and business leaders with deep expertise in gene therapy. The company is headquartered in New York City.
New York, NY, USA
Founded in 2018
Inaccurate data? Flag it here.
Open jobs at LEXEO Therapeutics
We only use strictly necessary, first-party cookies on this job board. These are cookies that are necessary to deliver this service to you, or are necessary for Venturesome by Recruit Rockstars to understand how it is being used. Read our Cookie Policy.